help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0921
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/12/6529    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anttonen, M.
Right arrow Articles by Heikinheimo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anttonen, M.
Right arrow Articles by Heikinheimo, M.
Related Collections
Right arrow Endocrine Oncology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 12 6529-6535
Copyright © 2005 by The Endocrine Society

High GATA-4 Expression Associates with Aggressive Behavior, whereas Low Anti-Müllerian Hormone Expression Associates with Growth Potential of Ovarian Granulosa Cell Tumors

Mikko Anttonen, Leila Unkila-Kallio, Arto Leminen, Ralf Butzow and Markku Heikinheimo

Children’s Hospital and Program for Developmental and Reproductive Biology (M.A., M.H.), Biomedicum Helsinki, and Departments of Obstetrics and Gynecology (L.U.-K., A.L., R.B.) and Pathology (R.B.), University of Helsinki, 00014 Helsinki, Finland; and Department of Pediatrics (M.H.), Washington University School of Medicine, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: Mikko Anttonen, M.B., Ph.D., Program for Developmental and Reproductive Biology, Biomedicum Helsinki, University of Helsinki, P.O. Box 63 (Haartmaninkatu 8), 00014 Helsinki, Finland. E-mail: mikko.anttonen{at}helsinki.fi.

Context: Granulosa cell tumors (GCTs) are ovarian malignancies that produce estrogens, inhibins, and anti-Müllerian hormone (AMH). The molecular pathogenesis of GCTs is likely to involve defects in the genes regulating normal granulosa cell proliferation during folliculogenesis.

Objective: The objective of this study was to test the role of factors regulating the normal granulosa cell function, i.e. AMH, inhibin-{alpha}, SF-1 (steroidogenic factor-1), and GATA transcription factors in the pathobiology and clinical behavior of GCTs.

Design: We selected randomly a cohort of 80 GCT patients treated at our university hospital during 1971–2003, analyzed protein expression in the tumor samples embedded on a tissue microarray by immunohistochemistry, and correlated the data to clinical and histopathological parameters.

Results: We found no significant differences in the immunoreactivity levels of inhibin-{alpha}, GATA-6, FOG-2 (friend of GATA-2), or SF-1 in GCTs compared with normal granulosa cells. AMH expression was, however, low (i.e. reduced) in 69% of GCTs and correlated inversely with tumor size (P = 0.0025). In contrast, GATA-4 expression was high (i.e. resembled normal granulosa cells) in 44% of GCTs and correlated positively with clinical stage and recurrence (P = 0.0232 and P = 0.0038, respectively). Fifty of the 80 patients had a follow-up for at least 10 yr, and 13 of them had recurrence(s). In multivariate analysis of recurrence, the high GATA-4 expression remained the only independent factor (risk ratio, 9.2; 95% confidence interval, 2.0–43.3; P = 0.0048).

Conclusions: The more aggressive GCTs retain a high GATA-4 expression, whereas the larger tumors lose the proliferation-suppressing AMH expression. The high GATA-4 expression in GCTs may serve as a marker of poor prognosis.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Kyronlahti, M. Ramo, M. Tamminen, L. Unkila-Kallio, R. Butzow, A. Leminen, M. Nemer, N. Rahman, I. Huhtaniemi, M. Heikinheimo, et al.
GATA-4 Regulates Bcl-2 Expression in Ovarian Granulosa Cell Tumors
Endocrinology, November 1, 2008; 149(11): 5635 - 5642.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Y. Hui and H. A. LaVoie
GATA4 Reduction Enhances 3',5'-Cyclic Adenosine 5'-Monophosphate-Stimulated Steroidogenic Acute Regulatory Protein Messenger Ribonucleic Acid and Progesterone Production in Luteinized Porcine Granulosa Cells
Endocrinology, November 1, 2008; 149(11): 5557 - 5567.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
K. Miller and W G. McCluggage
Prognostic factors in ovarian adult granulosa cell tumour
J. Clin. Pathol., August 1, 2008; 61(8): 881 - 884.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo
Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease
Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Anttonen, H Parviainen, A Kyronlahti, M Bielinska, D B Wilson, O Ritvos, and M Heikinheimo
GATA-4 is a granulosa cell factor employed in inhibin-{alpha} activation by the TGF-{beta} pathway.
J. Mol. Endocrinol., June 1, 2006; 36(3): 557 - 568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society